Literature DB >> 35241640

Retracted: Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκB-PUMA Signaling.

Qiang Yin1, Shan Liu1, Anbing Dong2, Xiufang Mi3, Fengyun Hao4, Kejun Zhang2.   

Abstract

The in vitro experiments of TGF-ß1 and the results of RT-PCR could not be repeated. In order not to affect others, the authors have asked for a retraction. Reference: Qiang Yin, Shan Liu, Anbing Dong, Xiufang Mi, Fengyun Hao, Kejun Zhang. Targeting Transforming Growth Factor-Beta1 (TGF-ß1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFkappakB-PUMA Signaling. Med Sci Monit 2016; 22: 2267-2277. DOI: 10.12659/MSM.898702.

Entities:  

Year:  2022        PMID: 35241640      PMCID: PMC8902839          DOI: 10.12659/MSM.936562

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Retraction Notice: The in vitro experiments of TGF-β1 and the results of RT-PCR could not be repeated. In order not to affect others, the authors have asked for a retraction.
  1 in total

1.  Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling.

Authors:  Qiang Yin; Shan Liu; Anbing Dong; Xiufang Mi; Fengyun Hao; Kejun Zhang
Journal:  Med Sci Monit       Date:  2016-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.